Conference abstract
Chronic diseases and lethality among hospitalised covid-19 patients at bafoussam regional hospital in the west region of cameroon
Pan African Medical Journal - Conference Proceedings. 2023:18(2).03
Oct 2023.
doi: 10.11604/pamj-cp.2023.18.2.2045
Archived on: 03 Oct 2023
Contact the corresponding author
Keywords: Chronic disease, COVID-19, lethality
Oral presentation
Chronic diseases and lethality among hospitalised covid-19 patients at bafoussam regional hospital in the west region of cameroon
Nzinnou Mbiaketcha Imelda Sonia1,&, Buh Nkum Collins1, Tchio Nighie Ketina Hirma1, Ateudjieu Jérôme2
1M.A. SANTE, Cameroun, 2Division of Health Operations Research, Cameroon Ministry of Public, Yaounde, Cameroon
&Corresponding author
Introduction: estimating the risk of pre-existing comorbidities on coronavirus disease 2019 (COVID-19) lethality may promote the importance of targeting at-risk populations to improve survival. This study explored the contribution of exposure to some chronic diseases on the lethality of COVID-19.
Methods: this was a cross-sectional descriptive study nested with case-control. The data were collected from the records of all patients hospitalised at Bafoussam Regional Hospital from March 2020 to December 2021. Patients whose outcome was death were considered as cases and were matched to controls whose outcome was recovery concerning their sex. The effect of the history of chronic diseases on COVID-19 lethality was assessed by estimating odd ratios.
Results: of 645 included patients, 262(40.62%) were males, 128(19.84%) aged 65 years and above. The mean hospitalisation duration was 11.07 days. Of the 645 patients, 120(20.23%) deaths were recorded. On admission, 204 (31,62%) patients presented at least one chronic disease. The most presented chronic diseases were high blood pressure and diabetes presented by 73(11.32%) and 55(8.53%) patients respectively. History of diabetes (OR=2.71[1.19-6.18]) and AIDS (OR=3.64 [95% CI=1.04-12.71]) were associated with higher risks of death whereas history of high blood pressure did not affect this risk (OR=1.45 [95% CI=0.80-2.64])
Conclusion: diabetes and AIDS appear to increase the risk of death from COVID-19. We suggest that health authorities should prioritize this specific group in primary and secondary preventive interventions for COVID-19.
Chronic diseases and lethality among hospitalised covid-19 patients at bafoussam regional hospital in the west region of cameroon
Nzinnou Mbiaketcha Imelda Sonia1,&, Buh Nkum Collins1, Tchio Nighie Ketina Hirma1, Ateudjieu Jérôme2
1M.A. SANTE, Cameroun, 2Division of Health Operations Research, Cameroon Ministry of Public, Yaounde, Cameroon
&Corresponding author
Introduction: estimating the risk of pre-existing comorbidities on coronavirus disease 2019 (COVID-19) lethality may promote the importance of targeting at-risk populations to improve survival. This study explored the contribution of exposure to some chronic diseases on the lethality of COVID-19.
Methods: this was a cross-sectional descriptive study nested with case-control. The data were collected from the records of all patients hospitalised at Bafoussam Regional Hospital from March 2020 to December 2021. Patients whose outcome was death were considered as cases and were matched to controls whose outcome was recovery concerning their sex. The effect of the history of chronic diseases on COVID-19 lethality was assessed by estimating odd ratios.
Results: of 645 included patients, 262(40.62%) were males, 128(19.84%) aged 65 years and above. The mean hospitalisation duration was 11.07 days. Of the 645 patients, 120(20.23%) deaths were recorded. On admission, 204 (31,62%) patients presented at least one chronic disease. The most presented chronic diseases were high blood pressure and diabetes presented by 73(11.32%) and 55(8.53%) patients respectively. History of diabetes (OR=2.71[1.19-6.18]) and AIDS (OR=3.64 [95% CI=1.04-12.71]) were associated with higher risks of death whereas history of high blood pressure did not affect this risk (OR=1.45 [95% CI=0.80-2.64])
Conclusion: diabetes and AIDS appear to increase the risk of death from COVID-19. We suggest that health authorities should prioritize this specific group in primary and secondary preventive interventions for COVID-19.
